Clade Therapeutics Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Employees
-
68
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$39.7M
- Investors
-
1
Clade Therapeutics General Information
Description
Developer of cell therapies designed to treat cancer, auto-immunity and other life-threatening diseases. The company combines stem cell biology, immunology, regenerative medicine, and gene editing to expand the impact of cell therapy, with an initial focus on developing therapies based on thymocytes and other immune cells, enabling clients to get stem cell-derived medicines.
Contact Information
Website
www.cladetx.comCorporate Office
- 201 Brookline
- Suite 1002
- Boston, MA 02215
- United States
Corporate Office
- 201 Brookline
- Suite 1002
- Boston, MA 02215
- United States
Clade Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 11-Apr-2024 | $39.7M | Completed | Pre-Clinical Trials | ||
| 3. Accelerator/Incubator | 01-Jan-2022 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 30-Dec-2021 | $87M | $87M | Completed | Pre-Clinical Trials | |
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
Clade Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Clade Therapeutics Comparisons
Industry
Financing
Details
Clade Therapeutics Competitors (60)
One of Clade Therapeutics’s 60 competitors is Carisma Therapeutics, a Formerly VC-backed company based in Philadelphia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Carisma Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Poseida Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom |
Clade Therapeutics Patents
Clade Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024270788-A1 | Inhibiting natural killer cell cytotoxicity against cell therapies | Pending | 18-May-2023 | ||
| AU-2024270788-A9 | Inhibiting natural killer cell cytotoxicity against cell therapies | Pending | 18-May-2023 | ||
| EP-4713365-A1 | Inhibiting natural killer cell cytotoxicity against cell therapies | Pending | 18-May-2023 | ||
| WO-2024238934-A1 | Inhibiting natural killer cell cytotoxicity against cell therapies | Inactive | 18-May-2023 | ||
| AU-2024218505-A1 | Cd4 + and cd8 + single positive t cells and compositions and methods for generating the same | Pending | 08-Feb-2023 | C12N5/0638 |
Clade Therapeutics Signals
Clade Therapeutics Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bristol-Myers Squibb Foundation | Limited Partner | Minority | ||
| Emerson Collective | Impact Investing | Minority | ||
| LifeSci Venture Partners | Corporate Venture Capital | Minority | ||
| Syncona | Venture Capital | Minority | ||
| Tech Launch Arizona | Accelerator/Incubator |
Clade Therapeutics Acquisitions (1)
Clade Therapeutics’s most recent deal was a Merger/Acquisition with Gadeta. The deal was made on 02-Oct-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Gadeta | 02-Oct-2023 | Merger/Acquisition | Biotechnology |
Clade Therapeutics FAQs
-
When was Clade Therapeutics founded?
Clade Therapeutics was founded in 2020.
-
Where is Clade Therapeutics headquartered?
Clade Therapeutics is headquartered in Boston, MA.
-
What is the size of Clade Therapeutics?
Clade Therapeutics has 68 total employees.
-
What industry is Clade Therapeutics in?
Clade Therapeutics’s primary industry is Drug Discovery.
-
Is Clade Therapeutics a private or public company?
Clade Therapeutics is a Private company.
-
What is the current valuation of Clade Therapeutics?
The current valuation of Clade Therapeutics is .
-
What is Clade Therapeutics’s current revenue?
The current revenue for Clade Therapeutics is .
-
How much funding has Clade Therapeutics raised over time?
Clade Therapeutics has raised $87M.
-
Who are Clade Therapeutics’s investors?
Bristol-Myers Squibb Foundation, Emerson Collective, LifeSci Venture Partners, Syncona, and Tech Launch Arizona have invested in Clade Therapeutics.
-
Who are Clade Therapeutics’s competitors?
Carisma Therapeutics, Poseida Therapeutics, Kite Pharma, Intellia Therapeutics, and Adaptimmune Therapeutics are some of the 60 competitors of Clade Therapeutics.
-
When was Clade Therapeutics acquired?
Clade Therapeutics was acquired on 11-Apr-2024.
-
Who acquired Clade Therapeutics?
Clade Therapeutics was acquired by Century Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process